石藥集團 (1093.HK): 核心產品恩必普支撐未來增長 October 6, 2017

投資概要

– 創新藥銷售強勁增長,產品線不斷豐富

– 研發費用上升,在研產品支援未來增長

– 銷售網路擴張,覆蓋更多城市和醫院

About the author

Profile photo of Eurus Zhou

Eurus Zhou
Phillip Securities (HK)

Graduated from Hong Kong Polytechnic University, Master of Finance (Investment Management). Possess bachelor degree majoring in Financial Management from Southwestern University of Finance and Economics. Focus on industry prospect and corporate fundamentals to explore investment value and cover pharmaceutical and consumer industry.

Get access to all the latest market news, reports, technical analysis
by signing up for a free account today!